文献速递围术期管理与 ERAS疝与腹壁外科胃肠外科

美国外科各专科出院阿片类药物处方模式更新分析

An updated analysis of discharge opioid-prescribing patterns across surgical specialties in the USA.
PubMed 文献 · Surg Endosc · 2026-10-21

基于2024年ACS-NSQIP数据库757,548例手术的横断面分析显示,74.71%患者出院时获阿片类处方,各专科中位日剂量30-45 MME/day,4.1%患者获得续方;调整后处方概率从心脏手术54.1%到胸科手术85.3%不等。

要点

  • 出院阿片类处方率整体达74.71%,各专科差异显著。
  • 各专科中位日剂量30-45 MME/day,4.1%患者获续方。
  • 腹腔镜疝修补等5类手术调整后处方概率超83%。

核心结论

  • 研究提供了美国外科各专科及高量手术术后出院阿片类处方模式的更新描述性基准。

研究设计与样本

  • 横断面分析,使用2024年美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库,纳入757,548例选定手术的成人患者。

主要发现

  • 565,959例(74.71%)患者出院时获得阿片类处方。
  • 各专科中位日阿片剂量范围为30至45 MME/day,4.1%患者获得续方。
  • 调整后出院阿片处方概率从心脏手术54.1%(95%CI 52.0%-55.9%)和血管手术60.0%(95%CI 59.2%-60.7%)到骨科84.3%(95%CI 84.1-84.5%)和胸科手术85.3%(95%CI 84.7-85.9%)。
  • 腹腔镜疝修补、膝关节置换、髋关节置换、脊柱融合、椎板切除/椎体切除各术式调整后出院阿片处方概率均超过83%。

临床怎么用

  • 可为外科各专科及高量术式提供出院阿片处方模式的基准参考,以识别处方差异并指导减少差异的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid overdose still accounts for substantial deaths and hospitalizations in the United States. Opioids continue to be commonly prescribed for postoperative pain. Although variation in postoperative opioid prescribing has been previously described, contemporary national data using newly available discharge-prescribing variables may provide useful benchmarks across surgical specialties and procedures. We sought to describe current patterns of opioid prescribing at discharge across surgical specialties and high-volume procedures in the United States. METHODS: This cross-sectional analysis used the 2024 American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database and included adults undergoing selected procedures in the United States. The primary outcomes were the receipt of an opioid prescription at discharge and quantify the daily discharge opioid dose, expressed as morphine milligram equivalents per day (MME/day). RESULTS: Among 757,548 selected surgical procedures (mean [SD] age of patients, 56.35 [16.97] years; 441,799 [58.32%] female patients), 565,959 patients (74.71%) received an opioid prescription at discharge. Median daily opioid doses ranged from 30 to 45 MME/day across surgical specialties, and 4.1% of patients received a refill. Adjusted probabilities of receiving an opioid prescription at discharge varied by specialty: from 54.1% (95% CI 52.0%-55.9%) in cardiac surgery and 60.0% (95% CI 59.2%-60.7%) in vascular surgery to 84.3% (95% CI 84.1-84.5%) in orthopedics and 85.3% (95% CI, 84.7-85.9%) in thoracic surgery. Laparoscopic hernia repair, knee arthroplasty, hip arthroplasty, spine fusion, and laminectomy/corpectomy each had an adjusted probability of opioid prescription at discharge that exceeded 83%. CONCLUSIONS AND RELEVANCE: This study provides an updated descriptive benchmark of postoperative opioid-prescribing patterns across surgical specialties and selected high-volume procedures. This evidence offers a foundation for strategic actions to reduce variation and improve patient care.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Filardi KFXC, Saeidishahri S, Wu Y, et al. An updated analysis of discharge opioid-prescribing patterns across surgical specialties in the USA. Surg Endosc. 2026. PMID: 42907591. doi:10.1007/s00464-026-13518-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。